KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001366244-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
57,426
Total Value
$292,646.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 23,250 | โ | โ | 490,915 | Direct | โ | View Details | |
Director | Common Stock | โ | May 22, 2026 | Sale | 10,926 | $26.78 | $292,646.35 | 479,989 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | May 21, 2026 | Exercise/Conversion | 23,250 | $0.00 | $0.00 | 255,750 | Direct | โ | View Details |